NM_001963.6:c.2491+1106A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_001963.6(EGF):​c.2491+1106A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0126 in 152,292 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.013 ( 23 hom., cov: 32)

Consequence

EGF
NM_001963.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0390

Publications

4 publications found
Variant links:
Genes affected
EGF (HGNC:3229): (epidermal growth factor) This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
EGF Gene-Disease associations (from GenCC):
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypomagnesemia 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0126 (1926/152292) while in subpopulation NFE AF = 0.017 (1157/68022). AF 95% confidence interval is 0.0162. There are 23 homozygotes in GnomAd4. There are 940 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1926 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001963.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
NM_001963.6
MANE Select
c.2491+1106A>G
intron
N/ANP_001954.2
EGF
NM_001178130.3
c.2491+1106A>G
intron
N/ANP_001171601.1
EGF
NM_001178131.3
c.2365+1106A>G
intron
N/ANP_001171602.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGF
ENST00000265171.10
TSL:1 MANE Select
c.2491+1106A>G
intron
N/AENSP00000265171.5
EGF
ENST00000503392.1
TSL:1
c.2491+1106A>G
intron
N/AENSP00000421384.1
EGF
ENST00000509996.1
TSL:1
n.419+1106A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0126
AC:
1924
AN:
152174
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00280
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0129
Gnomad ASJ
AF:
0.0297
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.0232
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0170
Gnomad OTH
AF:
0.0182
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0126
AC:
1926
AN:
152292
Hom.:
23
Cov.:
32
AF XY:
0.0126
AC XY:
940
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.00279
AC:
116
AN:
41574
American (AMR)
AF:
0.0129
AC:
197
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0297
AC:
103
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00249
AC:
12
AN:
4822
European-Finnish (FIN)
AF:
0.0232
AC:
246
AN:
10614
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0170
AC:
1157
AN:
68022
Other (OTH)
AF:
0.0185
AC:
39
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0159
Hom.:
31
Bravo
AF:
0.0116
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.9
DANN
Benign
0.67
PhyloP100
-0.039
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11569033; hg19: chr4-110905803; API